Search Results 751-760 of 29908 for Pulmonary

  1. Publications - James P. Utz, M.D. - Mayo Clinic

    Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med. 2008 Nov 1; 178(9):948-55. Epub ...

  2. Twin Sisters Share Many Things in Life, Including New Lungs

    ... pulmonary fibrosis (IPF), a potentially fatal lung disease that necessitated ... pulmonary evaluation. Both sisters' conditions were deteriorating ...

  3. Polysomnography (sleep study) - Mayo Clinic

    Your health care provider may order this test if a sleep disorder such as sleep apnea is suspected. Learn how to prepare and what to expect.

  4. Publications - Darin White, M.D. - Mayo Clinic

    Observer Performance for Detection of Pulmonary Nodules at Chest CT over a Large Range of Radiation Dose Levels. Radiology. 2020 Dec; 297(3):699-707. Epub 2020 ...

  5. Hypoplastic left heart syndrome - Diagnosis and treatment - Mayo Clinic

    ... pulmonary arteries. This allows the right ventricle to pump blood to both ... Surgeons implant a stent in the ductus arteriosus to maintain the opening between ...

  6. A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

    ... Pulmonary Disease (COPD). Print details. Share; Facebook ... Pulmonary rehabilitation: Subjects who have participated in the acute phase of a Pulmonary ...

  7. Bundle branch block - Symptoms & causes - Mayo Clinic

    Blood clot in the lungs (pulmonary embolism) · Heart attack (myocardial infarction) · Heart structure problems that are present at birth (congenital heart defects) ...

  8. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

    About this study. The purpose of this study is to determine if Simtuzumab (GS-6624) is safe and effective in treating Idiopathic Pulmonary Fibrosis.

  9. Pirfenidone (Oral Route) Proper Use - Mayo Clinic

    For oral dosage forms (capsules or tablets):. For idiopathic pulmonary fibrosis: Adults—On Days 1 to 7, 267 milligrams (mg) 3 times a day. On Days 8 ...

  10. A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease - Mayo Clinic

    A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary ...